Financhill
Back

HUTCHMED (China) Quote, Financials, Valuation and Earnings

HUTCHMED (China) Price Quote

$18.42
+1.04 (+5.98%)
(Updated: November 27, 2024 at 5:55 PM ET)

HUTCHMED (China) Key Stats

Buy
58
HUTCHMED (China) (HCM) is a Buy

Day range:
$17.16 - $17.74
52-week range:
$11.93 - $21.92
Dividend yield:
0%
P/E ratio:
28.97
P/S ratio:
7.21
P/B ratio:
4.01%

Volume:
100.3K
Avg. volume:
86.5K
1-year change:
-9.71%
Market cap:
$3B
Revenue:
$838M
EPS:
$-0.25

How Much Does HUTCHMED (China) Make?

Is HUTCHMED (China) Growing As A Company?

  • What Is HUTCHMED (China)'s Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.52%
  • What Is HUTCHMED (China)'s EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

HUTCHMED (China) Stock Price Performance

  • Did HUTCHMED (China) Stock Go Up Last Month?
    HUTCHMED (China) share price went down by -16.64% last month
  • Did HCM's Share Price Rise Over The Last Year?
    HCM share price fell by -9.71% over the past 1 year

What Is HUTCHMED (China) 52-Week High & Low?

HUTCHMED (China) Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy HUTCHMED (China)?

  • How Much Debt Does HUTCHMED (China) Have?
    Total long term debt quarterly is $82.1M
  • How Much Cash Does HUTCHMED (China) Have?
    Cash and short term investments quarterly total is $802.5M
  • What Is HUTCHMED (China)’s Book Value Per Share?
    Book value per share is 4.33

Is HUTCHMED (China) Cash Flow Positive?

  • What Is HCM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$47M
  • What Is HUTCHMED (China)’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.3M
  • What Is HUTCHMED (China)’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $19.4M

HUTCHMED (China) Return On Invested Capital

  • Is Management Doing A Good Job?
    HCM return on invested capital is -5.04%
  • What Is HUTCHMED (China) Return On Assets?
    ROA measures how assets are converting to revenues and is -3.28%
  • What Is HCM Return On Equity?
    ROE is a measure of profitability and is -5.49%

HUTCHMED (China) Earnings Date & Stock Price

HUTCHMED (China) Competitors

  • Who Are HUTCHMED (China)'s Competitors?
    Below is a list of companies who compete with HUTCHMED (China) or are related in some way:
    • AstraZeneca PLC (AZN)
    • Prenetics Global Ltd (PRE)
    • Regencell Bioscience Holdings Ltd (RGC)
    • Sino Biopharmaceutical Ltd (SBMFF)
    • Takeda Pharmaceutical Co Ltd (TAK)

HUTCHMED (China) Dividend Yield

HUTCHMED (China) Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 51.52% 0%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 28.53
Upside from Last Price: 64.16%

Major Shareholders

  • How many HCM shares are owned by institutional investors?
    11M HCM shares are owned by institutional investors
  • How many HCM shares are owned by insiders?
    23.7M HCM shares are owned by insiders